This company listing is no longer active
Virtus Health Past Earnings Performance
Past criteria checks 4/6
Key information
-3.88%
Earnings growth rate
-4.02%
EPS growth rate
Healthcare Industry Growth | 2.43% |
Revenue growth rate | 5.25% |
Return on equity | 8.46% |
Net Margin | 8.45% |
Last Earnings Update | 31 Dec 2021 |
Recent past performance updates
Recent updates
Virtus Health (ASX:VRT) Will Pay A Dividend Of AU$0.12
Mar 03What Is Virtus Health Limited's (ASX:VRT) Share Price Doing?
Dec 14Slowing Rates Of Return At Virtus Health (ASX:VRT) Leave Little Room For Excitement
Jun 03Is Now An Opportune Moment To Examine Virtus Health Limited (ASX:VRT)?
May 14Virtus Health Limited's (ASX:VRT) Intrinsic Value Is Potentially 73% Above Its Share Price
Apr 13Here's Why Virtus Health (ASX:VRT) Can Manage Its Debt Responsibly
Mar 29Is Virtus Health Limited (ASX:VRT) Popular Amongst Institutions?
Mar 17Virtus Health Limited's (ASX:VRT) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?
Mar 05Some Investors May Be Willing To Look Past Virtus Health's (ASX:VRT) Soft Earnings
Feb 22What Do The Returns On Capital At Virtus Health (ASX:VRT) Tell Us?
Feb 16Virtus Health (ASX:VRT) Shareholders Have Enjoyed A 23% Share Price Gain
Jan 26Need To Know: Virtus Health Limited (ASX:VRT) Insiders Have Been Buying Shares
Jan 05What Type Of Shareholders Own The Most Number of Virtus Health Limited (ASX:VRT) Shares?
Dec 13Is Virtus Health (ASX:VRT) A Risky Investment?
Nov 25There Is A Reason Virtus Health Limited's (ASX:VRT) Price Is Undemanding
Aug 13How Much Are Virtus Health Limited (ASX:VRT) Insiders Spending On Buying Shares?
Jul 29What Does Virtus Health Limited's (ASX:VRT) Share Price Indicate?
Jul 14Does Virtus Health Limited's (ASX:VRT) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Jun 18Revenue & Expenses Breakdown
How Virtus Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 21 | 335 | 28 | 17 | 0 |
30 Sep 21 | 335 | 36 | 16 | 0 |
30 Jun 21 | 334 | 43 | 15 | 0 |
31 Mar 21 | 315 | 29 | 15 | 0 |
31 Dec 20 | 296 | 15 | 15 | 0 |
30 Sep 20 | 282 | 8 | 15 | 0 |
30 Jun 20 | 268 | 0 | 15 | 0 |
31 Mar 20 | 275 | 15 | 18 | 0 |
31 Dec 19 | 282 | 29 | 21 | 0 |
30 Sep 19 | 282 | 29 | 24 | 0 |
30 Jun 19 | 281 | 28 | 28 | 0 |
31 Mar 19 | 276 | 29 | 27 | 0 |
31 Dec 18 | 271 | 29 | 27 | 0 |
30 Sep 18 | 268 | 30 | 26 | 0 |
30 Jun 18 | 264 | 31 | 25 | 0 |
31 Mar 18 | 261 | 30 | 24 | 0 |
31 Dec 17 | 259 | 30 | 23 | 0 |
30 Sep 17 | 258 | 29 | 23 | 0 |
30 Jun 17 | 257 | 28 | 23 | 0 |
31 Mar 17 | 258 | 29 | 23 | 0 |
31 Dec 16 | 260 | 30 | 24 | 0 |
30 Sep 16 | 261 | 31 | 23 | 0 |
30 Jun 16 | 261 | 33 | 23 | 0 |
31 Mar 16 | 257 | 32 | 22 | 0 |
31 Dec 15 | 252 | 31 | 21 | 0 |
30 Sep 15 | 243 | 30 | 21 | 0 |
Quality Earnings: VRT has high quality earnings.
Growing Profit Margin: VRT's current net profit margins (8.4%) are higher than last year (5.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VRT's earnings have declined by 3.9% per year over the past 5 years.
Accelerating Growth: VRT's earnings growth over the past year (83.6%) exceeds its 5-year average (-3.9% per year).
Earnings vs Industry: VRT earnings growth over the past year (83.6%) exceeded the Healthcare industry 29.8%.
Return on Equity
High ROE: VRT's Return on Equity (8.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/08/07 04:36 |
End of Day Share Price | 2022/08/01 00:00 |
Earnings | 2021/12/31 |
Annual Earnings | 2021/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Virtus Health Limited is covered by 10 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Hester | Bell Potter |
David Stanton | CLSA |
David Stanton | Jefferies LLC |